Immobilized fibrinogen activates human platelets through glycoprotein VI PH Mangin, MB Onselaer, N Receveur, N Le Lay, AT Hardy, C Wilson, ... haematologica 103 (5), 898, 2018 | 144 | 2018 |
Function of Ikaros as a tumor suppressor in B cell acute lymphoblastic leukemia P Kastner, A Dupuis, MP Gaub, R Herbrecht, P Lutz, S Chan American journal of blood research 3 (1), 1, 2013 | 87 | 2013 |
Validation of the ISTH/SSC bleeding assessment tool for inherited platelet disorders: a communication from the Platelet Physiology SSC P Gresele, S Orsini, P Noris, E Falcinelli, MC Alessi, L Bury, M Borhany, ... Journal of Thrombosis and Haemostasis 18 (3), 732-739, 2020 | 84 | 2020 |
Biclonal and biallelic deletions occur in 20% of B-ALL cases with IKZF1 mutations A Dupuis, MP Gaub, M Legrain, B Drenou, L Mauvieux, P Lutz, ... Leukemia 27 (2), 503-507, 2013 | 82 | 2013 |
Platelet preparation for function testing in the laboratory and clinic: Historical and practical aspects B Hechler, A Dupuis, PH Mangin, C Gachet Research and practice in thrombosis and haemostasis 3 (4), 615-625, 2019 | 60 | 2019 |
Identification of a new dysfunctional platelet P2Y12 receptor variant associated with bleeding diathesis A Lecchi, C Razzari, S Paoletta, A Dupuis, L Nakamura, P Ohlmann, ... Blood, The Journal of the American Society of Hematology 125 (6), 1006-1013, 2015 | 55 | 2015 |
Platelet δ-storage pool disease: an update A Dupuis, JC Bordet, A Eckly, C Gachet Journal of clinical medicine 9 (8), 2508, 2020 | 54 | 2020 |
An essential role for α4A-tubulin in platelet biogenesis C Strassel, MM Magiera, A Dupuis, M Batzenschlager, A Hovasse, ... Life science alliance 2 (1), 2019 | 45 | 2019 |
Inherited platelet disorders: Management of the bleeding risk A Dupuis, C Gachet Transfusion Clinique et Biologique 25 (3), 228-235, 2018 | 30 | 2018 |
Cell surface expression of HLA I molecules as a marker of young platelets C Angénieux, A Dupuis, C Gachet, H de la Salle, B Maître Journal of Thrombosis and Haemostasis 17 (9), 1511-1521, 2019 | 27 | 2019 |
The ISTH bleeding assessment tool as predictor of bleeding events in inherited platelet disorders: Communication from the ISTH SSC Subcommittee on Platelet Physiology P Gresele, E Falcinelli, L Bury, A Pecci, MC Alessi, M Borhany, PG Heller, ... Journal of Thrombosis and Haemostasis 19 (5), 1364-1371, 2021 | 26 | 2021 |
Inherited dysfunctional platelet P2Y12 receptor mutations associated with bleeding disorders A Lecchi, EA Femia, S Paoletta, A Dupuis, P Ohlmann, C Gachet, ... Haemostaseologie 36 (04), 279-283, 2016 | 22 | 2016 |
Antithrombotic prophylaxis for surgery-associated venous thromboembolism risk in patients with inherited platelet disorders. The SPATA-DVT Study F Paciullo, L Bury, P Noris, E Falcinelli, F Melazzini, S Orsini, C Zaninetti, ... haematologica 105 (7), 1948, 2020 | 12 | 2020 |
The contribution of mouse models to the understanding of constitutional thrombocytopenia C Léon, A Dupuis, C Gachet, F Lanza haematologica 101 (8), 896, 2016 | 11 | 2016 |
Haemorrhagic and thrombotic diatheses in mouse models with thrombocytosis C Strassel, L Kubovcakova, PH Mangin, C Ravanat, M Freund, RC Skoda, ... Thrombosis and Haemostasis 114 (02), 414-425, 2015 | 11 | 2015 |
A novel platelet-type von Willebrand disease mutation (GP1BA p. Met255Ile) associated with type 2B “Malmö/New York” von Willebrand disease C Lavenu-Bombled, C Guitton, A Dupuis, MJ Baas, C Desconclois, ... Thrombosis and Haemostasis 116 (12), 1070-1078, 2016 | 10 | 2016 |
High prevalence of the natural Asn89Asp mutation in the GP1BB gene associated with Bernard–Soulier syndrome in French patients from the genetic isolate of Reunion Island M Fiore, C De Thoré, H Randrianaivo-Ranjatoelina, MJ Baas, ... British journal of haematology 189 (3), e67, 2020 | 8 | 2020 |
In vitro quality of amotosalen‐UVA pathogen‐inactivated mini‐pool plasma prepared from whole blood stored overnight C Ravanat, A Dupuis, N Marpaux, C Naegelen, G Mourey, H Isola, ... Vox Sanguinis 113 (7), 622-631, 2018 | 7 | 2018 |
Anti-HLA Class I alloantibodies in platelet transfusion refractoriness: From mechanisms and determinants to therapeutic prospects A Couvidou, G Rojas-Jiménez, A Dupuis, B Maître Frontiers in Immunology 14, 1125367, 2023 | 6 | 2023 |
Pathogenic and likely pathogenic variants in at least five genes account for approximately 3% of mild isolated nonsyndromic thrombocytopenia P Guéguen, A Dupuis, JY Py, A Desprès, E Masson, C Le Marechal, ... Transfusion 60 (10), 2419-2431, 2020 | 6 | 2020 |